Table 1.
Characteristics of 249 patients with pancreatic surgery for a malignancy in the western part of the Netherlands between 1996 and 2008
| 1996–2000 N (%) | 2001–2005 N (%) | 2006–2008 N (%) | P value | |
|---|---|---|---|---|
| Total No. of patients | 85 | 89 | 110 | |
| Gender | ||||
| Male | 40 (47.1) | 48 (53.9) | 52 (47.3) | .572 |
| Female | 45 (52.9) | 41 (46.1) | 58 (52.7) | |
| Age | ||||
| <50 years | 13 (15.3) | 16 (18.0) | 9 (8.2) | .218 |
| 50–74 years | 60 (70.6) | 64 (71.9) | 82 (74.5) | |
| ≥75 years | 12 (14.1) | 9 (10.1) | 19 (17.3) | |
| Tumor location | ||||
| Pancreas | 45 (52.9) | 60 (67.4) | 78 (70.9) | .046 |
| Extrahepatic bile duct | 29 (34.1) | 16 (18.0) | 22 (20.0) | |
| Duodenum | 11 (12.9) | 13 (14.6) | 10 (9.1) | |
| Histology | ||||
| Adenocarcinoma | 72 (84.7) | 71 (79.8) | 98 (89.1) | .190 |
| Othera | 13 (15.3) | 18 (20.2) | 12 (10.9) | |
| Stage (pTNM) | ||||
| I–II | 41 (48.2) | 38 (42.7) | 40 (36.4) | .073 |
| III–IV | 33 (38.8) | 31 (34.8) | 56 (50.9) | |
| Other | 11 (12.9) | 20 (22.5) | 14 (12.7) | |
| Chemotherapy | ||||
| Yes | 2 (2.4) | 5 (5.6) | 26 (23.6) | .000 |
| No | 83 (97.6) | 84 (94.4) | 84 (76.4) | |
| Radiotherapy | ||||
| Yes | 5 (5.9) | 3 (3.4) | 0 | |
| No | 80 (94.1) | 86 (96.6) | 110 (100) | |
aOther histology includes (neuro)endocrine tumors, carcinoid tumors, and unspecified histology